• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

BioTime Inc.

economics regenerative medicine stemells tissue engineering regmed

  • Please log in to reply
777 replies to this topic

#691 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 16 June 2016 - 05:03 PM

Checking on Unusual Volume for: BioTime, Inc. (:BTX)
Franklin Independent - 7 hours ago
Shares of BioTime, Inc. (:BTX) are experiencing unusual volume during today's trading. While the stock price moved along with the volume change, shares are touching $2.44 at the time of writing.

View the full article

#692 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 16 June 2016 - 05:26 PM

Shares Down in Trading Session: BioTime, Inc. (:BTX)
The Post - 10 hours ago
BioTime, Inc. (:BTX) is seeing heavy declines so far in today's trading session. Shares are moving -5.77% lower on solid volume.

View the full article

#693 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 17 June 2016 - 01:30 PM

BioTime, Inc. (NYSEMKT:BTX) Eyes $17.5 Million IPO
Scibility Media - 44 minutes ago
BioTime, Inc. (NYSEMKT: BTX) has kicked off a process for a secondary IPO that is expected to net nearly $17.5 million in gross proceeds.

View the full article

sponsored ad

  • Advert

#694 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 17 June 2016 - 05:26 PM

Reviewing Unusual Volume for: BioTime, Inc. (:BTX)
Franklin Independent - 17 minutes ago
Shares of BioTime, Inc. (:BTX) are experiencing unusual volume during today's trading. While the stock price moved along with the volume change, shares are touching $2.39 at the time of writing.

View the full article

#695 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 17 June 2016 - 05:26 PM

Reviewing Unusual Volume for: BioTime, Inc. (:BTX)
Franklin Independent - 3 hours ago
Shares of BioTime, Inc. (:BTX) are experiencing unusual volume during today's trading. While the stock price moved along with the volume change, shares are touching $2.39 at the time of writing.

View the full article

#696 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 17 June 2016 - 09:22 PM

BioTime Inc. (BTX) Drops 7.69% on June 16
Equities.com - 3 hours ago
BioTime Inc. (BTX) was one of the Russell 2000's biggest losers for Thursday June 16 as the stock slid 7.69% to $2.40, a loss of $-0.2 per share.

View the full article

#697 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 20 June 2016 - 01:07 PM

Active Stocks: BioTime, Inc. (NYSEMKT:BTX), Valmont Industries, Inc. (NYSE:VMI ...
Benchmark Monitor - 9 hours ago
BioTime, Inc. (NYSE MKT:BTX), announced its intent to offer to sell shares of its common stock in an underwritten public offering.

View the full article

#698 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 15 June 2016 - 08:42 PM

BioTime initiates equity offering; shares down 4% after hours
Seeking Alpha - Jun 15, 2016
BioTime (NYSEMKT:BTX) commences a public offering of common stock. Price, volume and terms have yet to be announced. Shares are off 4% after hours on increased volume.

View the full article

#699 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 21 June 2016 - 03:45 PM

BioTime, Inc. Announces Closing of Public Offering of Common Stock
Business Wire (press release) - 3 hours ago
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX), a clinical-stage biotechnology company focused on developing and commercializing novel therapies in the field of regenerative medicine, today announced the closing of its previously ...

View the full article

#700 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 21 June 2016 - 03:45 PM

BioTime, Inc. Announces Closing of Public Offering of Common Stock
Business Wire (press release) - 6 hours ago
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX), a clinical-stage biotechnology company focused on developing and commercializing novel therapies in the field of regenerative medicine, today announced the closing of its previously ...

View the full article

#701 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 23 June 2016 - 11:15 PM

BioTime, Inc. (BTX) Director Purchases $6531000.04 in Stock
Community Financial News - 29 minutes ago
BioTime logo BioTime, Inc. (NYSEMKT:BTX) Director Broadwood Partners Lp purchased 2,732,636 shares of the firm's stock in a transaction that occurred on Tuesday, June 21st.

View the full article

#702 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 27 June 2016 - 01:07 PM

Stocks to Watch: Mondelez International, Inc. (NASDAQ:MDLZ), BioTime, Inc ...
Benchmark Monitor - 2 hours ago
Mondelēz International Inc. (NASDAQ:MDLZ) published its Call For Well-being 2015 Progress Report. The report details how the world's leading snacking company exceeded nearly all of its 2015 environmental footprint goals and set more aggressive 2020 ...

View the full article

#703 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 30 June 2016 - 04:18 PM

BioTime, Inc. Stock Price Increases Today
Engelwood Daily - 26 minutes ago
The stock of BioTime, Inc. (NYSEMKT:BTX) is a huge mover today! The stock is up 4.80% or $0.12 after the news, hitting $2.62 per share.

View the full article

#704 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 23 June 2016 - 01:08 PM

BioTime, Inc. versus Cellular Biomedicine Group Inc. Head to Head Compare
CML News - Jun 23, 2016
These companies have the same star rating so the head-to-head compare will rely on a deep dive into specific metric comparisons. The CML Star Rating is an objective, quantifiable measure of a company's operating and financial condition.

View the full article

#705 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 05 July 2016 - 03:33 PM

BioTime, Inc. Announces Full Exercise and Closing of Underwriters' Over ...
Yahoo Finance - 11 minutes ago
BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company focused on developing and commercializing novel therapies in the field of regenerative medicine, today announced that the underwriters of BioTime, Inc.'s previously announced public ...

View the full article

#706 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 05 July 2016 - 03:33 PM

BioTime, Inc. Announces Full Exercise and Closing of Underwriters' Over ...
Business Wire (press release) - 3 hours ago
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company focused on developing and commercializing novel therapies in the field of regenerative medicine, today announced that the underwriters of ...

View the full article

#707 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 07 July 2016 - 06:45 PM

BioTime, Inc. Stock Momentum at Critical Inflection Point
CML News - 1 hour ago
This is a momentum stock rating analysis for BioTime, Inc. (AMEX:BTX) . The company has a three bull momentum rating which indicates an inflection point.

View the full article

#708 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 11 July 2016 - 12:22 PM

BioTime Inc. (BTX) Position Raised by Broadwood Capital Inc.
BBNS - 2 hours ago
BioTime logo Broadwood Capital Inc. increased its position in shares of BioTime Inc. (NYSEMKT:BTX) by 1.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).

View the full article

#709 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 11 July 2016 - 06:33 PM

Sentiment Report: Biotime Inc (CVE:ATW)
Consumer Eagle - 11 minutes ago
Biotime Inc (CVE:ATW) institutional sentiment decreased to 0.96 in 2016 Q1. Its down -0.12, from 1.08 in 2015Q4. The ratio has worsened, as 24 institutional investors opened new or increased holdings, while 25 sold and trimmed positions in Biotime Inc ...

View the full article

#710 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 11 July 2016 - 06:41 PM

Sentiment Report: Biotime Inc (CVE:ATW)
Consumer Eagle - 7 hours ago
Biotime Inc (CVE:ATW) institutional sentiment decreased to 0.96 in 2016 Q1. Its down -0.12, from 1.08 in 2015Q4. The ratio has worsened, as 24 institutional investors opened new or increased holdings, while 25 sold and trimmed positions in Biotime Inc ...

View the full article

#711 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 13 July 2016 - 10:34 PM

Insiders Increasing Positions in: BioTime, Inc. (:BTX)
Press Telegraph - 18 hours ago
According to the latest SEC filings, insiders at BioTime, Inc. (:BTX) have increased their position in the stock by 10.00% over the past 6 months.

View the full article

#712 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 13 July 2016 - 10:34 PM

Insiders Increasing Positions in: BioTime, Inc. (:BTX)
Press Telegraph - 21 hours ago
According to the latest SEC filings, insiders at BioTime, Inc. (:BTX) have increased their position in the stock by 10.00% over the past 6 months.

View the full article

#713 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 20 July 2016 - 03:05 PM

Increased Stock Volatility Watch: BioTime, Inc. (:BTX)
Engelwood Daily - 11 hours ago
Shares of BioTime, Inc. (:BTX) are displaying high volatlity in today's session as the stock has changed 3.78%, clocking in at $3.02 with a recent bid.

View the full article

#714 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 21 July 2016 - 05:48 AM

Insiders Increasing Positions in: BioTime, Inc. (:BTX)
Press Telegraph - 7 hours ago
Wall Street analysts on the sell-side covering shares of BioTime, Inc. (:BTX) have a mean recommendation of 1.50 on the shares.

View the full article

#715 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 21 July 2016 - 04:18 PM

BioTime Inc (AMEX:BTX) Stock Volatility Hits An Unsually High Level
CML News - 43 minutes ago
This is a proprietary stock volatility rating created by Capital Market Laboratories (CMLviz) based on a large number of data interactions for BioTime Inc (AMEX:BTX) . We examine the little used gem of daily stock volatilty over a 20-day and 30-day ...

View the full article

#716 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 21 July 2016 - 06:03 AM

Insiders Increasing Positions in: BioTime, Inc. (:BTX)
Press Telegraph - 14 hours ago
Wall Street analysts on the sell-side covering shares of BioTime, Inc. (:BTX) have a mean recommendation of 1.50 on the shares.

View the full article

#717 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 22 July 2016 - 11:15 AM

Trending Stocks: Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS), BioTime, Inc ...
Benchmark Monitor - 2 hours ago
Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) traded 530715 shares on last trading day with closing price of $16.24. Company return on investment (ROI) is -44.90%.

View the full article

#718 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 22 July 2016 - 11:15 AM

Trending Stocks: Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS), BioTime, Inc ...
Benchmark Monitor - 6 hours ago
Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) traded 530715 shares on last trading day with closing price of $16.24. Company return on investment (ROI) is -44.90%.

View the full article

#719 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 27 July 2016 - 12:50 PM

BioTime, Inc. to Report Second Quarter Results on August 9, 2016
Yahoo Finance - 3 hours ago
BioTime, Inc. (NYSE MKT: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that it will release second quarter financial and operating results on Tuesday, August 9, 2016 after the ...

View the full article

#720 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 27 July 2016 - 12:45 PM

BioTime, Inc. to Report Second Quarter Results on August 9, 2016
Business Wire (press release) - 7 hours ago
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that it will release second quarter financial and operating results on ...
BioTime, Inc. on Focus After Raising In Today's Session - Press Telegraph

View the full article





Also tagged with one or more of these keywords: economics, regenerative medicine, stemells, tissue engineering, regmed

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users